Supraventricular Tachycardia

Clinical Trial Finder

Many patients with supraventricular tachycardia are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure

Conditions:   Atrial Fibrillation;   Atrial Flutter
Interventions:   Drug: bucindolol hydrochloride;   Drug: metoprolol succinate
Sponsors:   ARCA Biopharma, Inc.;   Medtronic
Recruiting - verified April 2014

ARIXTRA® Adherence in SVT Patients.

Condition:   Thrombosis, Venous
Intervention:   Drug: Fondaparinux
Sponsor:   GlaxoSmithKline
Active, not recruiting - verified April 2014

Get CardioSmart

You're Invited